Scientists Identify Novel Mechanism to Target Pancreatic Cancer Cells

Researchers at the University of Cologne have uncovered a previously unknown mechanism that makes most pancreatic cancer cells susceptible to programmed cell death. The study found that KRAS-mutated tumor cells continuously activate innate immune system signals, creating a vulnerability. This discovery, published in Nature Communications, opens new avenues for developing treatments for this aggressive cancer.